Your browser doesn't support javascript.
loading
Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case report.
Fujimoto, Kana; Watanabe, Satomi; Yasuda, Yuto; Date, Emi; Kawabata, Yasuhiro; Kanemura, Hiroaki; Takahama, Takayuki; Yonesaka, Kimio; Iizuka, Norishige; Takahashi, Ken-Ichi; Kawakami, Osamu; Ozaki, Tomohiro; Nakagawa, Kazuhiko.
Afiliação
  • Fujimoto K; Department of Respiratory Medicine, Kishiwada City Hospital, Kishiwada, Japan.
  • Watanabe S; Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Japan.
  • Yasuda Y; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Date E; Department of Respiratory Medicine, Kishiwada City Hospital, Kishiwada, Japan.
  • Kawabata Y; Department of Pathology, Kishiwada City Hospital, Kishiwada, Japan.
  • Kanemura H; Department of Neurosurgery, Kishiwada City Hospital, Kishiwada, Japan.
  • Takahama T; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Yonesaka K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Iizuka N; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Takahashi KI; Department of Pathology, Kishiwada City Hospital, Kishiwada, Japan.
  • Kawakami O; Department of Respiratory Medicine, Kishiwada City Hospital, Kishiwada, Japan.
  • Ozaki T; Department of Neurosurgery, Kishiwada City Hospital, Kishiwada, Japan.
  • Nakagawa K; Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Japan.
Thorac Cancer ; 14(2): 214-217, 2023 01.
Article em En | MEDLINE | ID: mdl-36495048
ABSTRACT
High-grade fetal lung adenocarcinoma (H-FLAC) is a rare tumor, with little known of its response to chemotherapy with or without an immune checkpoint inhibitor or of its molecular profile. We report the first case of a 56-year-old man with stage IV H-FLAC who was successfully treated with carboplatin plus nab-paclitaxel in combination with atezolizumab. In addition, the tumor was found to be positive for amplification of the human epidermal growth factor receptor 2 gene.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans / Male / Middle aged Idioma: En Revista: Thorac Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans / Male / Middle aged Idioma: En Revista: Thorac Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão